Chorioangioma of Placenta by Das, Rubby
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 1
Chorioangioma of Placenta
Rubby Das
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.79993
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
y  s
Additional infor ation is available at the end of the chapter
Abstract
The human placenta is a villous hemochorial structure. It is attached to the uterine wall 
and establishes connection between the mother and the fetus through the umbilical cord 
and thus plays a critical role in maternal fetal transfer. It is developed from two sources: 
fetal chorion frondosum and maternal decidua basalis. Various abnormal conditions 
have been reported with the placenta and the placental chorioangioma is one of them. 
Chorioangioma of placenta is the commonest benign tumor of the placenta. It consists 
of a benign angioma arising from the chorionic tissue. It has been found to be associated 
with many serious complications such as nonimmune hydrops, congenital abnormalities, 
hemolytic anemia, polyhydramnios, IUGR, and IUFD.
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1. Introduction
The human placenta is discoid in shape and is a villous hemochorial structure [1, 2]. The 
placenta is attached to the uterine wall and establishes connection between the mother and 
the fetus through the umbilical cord and thus plays a critical role in maternal fetal transfer [2]. 
It has a complex synthetic capacity and plays a role in the immunologic acceptance of fetal 
allograft [2].
2. Development
The placenta is developed from two sources. The principal component is fetal which develops 
from the chorion frondosum, and the maternal component consists of decidua basalis (Figure 1) [2]. 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The fertilized ovum converts into a morula and further differentiates into a blastocyst. The outer 
layer of the blastocyst proliferates to form the primary trophoblastic cell mass which infiltrates the 
endometrial lining. By the 7th post-ovulatory day, the trophoblast differentiates into two layers: 
an inner layer of clear mononuclear cells with well-defined limiting membranes called cytotro-
phoblast and the outer layer of multinucleated cells with no intercellular membrane called syncy-
tiotrophoblasts [1]. By 10th to 13th post-ovulatory days, a series of intercommunicating spaces or 
lacunae develop in the rapidly enlarging and dividing trophoblastic cell mass.
The lacunae become confluent, and as the trophoblastic cell erodes the maternal vessels, they 
become filled with blood to form intervillous spaces. Between the lacunae spaces, there are 
columns having a central core of cytotrophoblasts surrounded by syncytiotrophoblasts. These 
form the framework for the development of villi later. From these pillars, branching sprouts 
appear. Those columns extent as far as the decidua and a mesenchymal core develops in them 
to form extraembryonic mesenchyme, which forms the villus vessels. In due course, these 
vessels establish continuity with those developing from the body stalk and inner chorionic 
mesenchyme. The distal part of the columns is not invaded by the mesenchyme but only 
serves to anchor it to the basal plate [1, 3]. These cells proliferate and spread laterally separat-
ing the syncytiotrophoblasts into two layers, the definitive syncytium on the fetal aspect and 
the peripheral syncytium on the decidual side which eventually degenerates and is replaced 
by a fibrinoid material and is known as Nitabuch’s layer.
With deeper blastocyst invasion into the decidua, the extravillous cytotrophoblasts give rise 
to solid primary villi composed of a cytotrophoblast core covered by syncytium. The most 
deeply implanted portion of these villi forms placenta (Figure 2). Beginning on the 12th day 
Figure 1. Decidual structure differentiating into decidua basalis, capsularis, and parietalis.
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after fertilization, chorionic villi can first be distinguished and form secondary villi. After 
angiogenesis begins in the mesenchymal cores, it results into tertiary villi.
By approximately the 17th day, fetal blood vessels are functional, and a placental circulation is 
established. The placenta is a vascularized villus structure by the 21st day. The fetal-placental 
circulation is completed when embryonic blood vessels are connected with chorionic vessels. 
Groups of cytotrophoblasts also grow into the lumen of the spiral arteries extending as far 
as the decidual myometrial junction. These cells destroy the muscular and the elastic layer of 
the vessel wall and get replaced by a fibrinoid material which is derived from the maternal 
blood and proteins secreted by the trophoblastic cells. This primary invasion dilates the spiral 
arteriolar wall and thus augments blood flow to the placenta [1, 3]. There is a secondary 
invasion of trophoblast between 12 and 16 weeks extending up to radial arteries within the 
myometrium. Thus, spiral arteries are converted to large bore uteroplacental arteries. The net 
effect is funneling of the arteries that reduce the pressure of the blood to 70–80 mm Hg before 
it reaches the intervillous space. It thus increases the blood flow.
The placental septa appear by 12 weeks protruding into the intervillous spaces from the basal plate 
and divide the placenta into 15–20 lobes. Until the end of the 16th week, the placenta grows both 
in thickness and circumference due to growth of the chorionic villi with accompanying expansion 
of the intervillous space and with continuous arborization and formation of fresh villi [2].
In the first trimester, the villi are large and have a mantle of trophoblasts consisting of an 
inner layer of cytotrophoblasts and an outer layer of syncytiotrophoblasts with the stroma of 
small fetal vessels. During the second trimester, the villi are smaller, the mantle is less regular 
and the cytotrophoblasts less numerous, and the stroma with more collagen. The fetal vessels 
Figure 2. Development of placenta.
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become larger and more toward the periphery of the villus. In the third trimester, the villi are 
much smaller in diameter, and the cytotrophoblasts are irregular and thinned out. The fetal 
vessels are dilated and lie just below the thinned out trophoblasts.
The placenta, at term, is almost a circular disc with a diameter of 15–20 cm and a thickness 
of about 3 cm at its center [2]. It feels spongy and weighs about 500 g, the proportion to the 
weight of the baby being roughly 1:  6 at term and occupies about 30% of the uterine wall. It 
presents two surfaces, fetal and maternal, and a peripheral margin (Figure 3) [2].
• The fetal surface is covered by the smooth and glistening amnion with the umbilical cord 
attached at or near its center [2].
• The maternal surface is rough and spongy. It consists of 15–20 lobes or cotyledons which 
are limited by fissures. Each fissure is occupied by the decidual septum which is derived 
from the basal plate [2].
The placenta consists of two plates. The chorionic plate lies internally. It is lined by the amni-
otic membrane. The umbilical cord is attached to this plate. The basal plate lies to the maternal 
aspect. Between the two plates lies the intervillous space containing the stem villi with their 
branches, the space being filled with maternal blood. A mature placenta has a volume of 
about 500 mL of blood, 350 mL being occupied in the villi system and 150 mL lying in the 
intervillous space [2].
3. Functions
1. Transfer of nutrients and waste products between the mother and the fetus. In this respect, 
it attributes to the following functions:
Figure 3. Placenta at term.
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• Respiratory
• Excretory
• Nutritive
2. Endocrine function: placenta is an endocrine gland. It produces both steroid and peptide 
hormones (like progesterone, estriol, human chorionic gonadotropin, and human placen-
tal lactogen) to maintain pregnancy and support fetal growth.
3. Barrier function: placenta acts as a protective mechanism.
4. Immunological function: maternal antibodies are taken into the syncytiotrophoblasts by 
pinocytosis and subsequently transferred to fetal capillaries and thus fetus acquires pas-
sive immunity (Figure 4).
4. Abnormalities of placenta
4.1. Placenta succenturiata
The accessory lobe is developed from the activated villi on the chorionic leave, may be 
placed at varying distances from the main placental margin. A leash of vessels connecting 
the main to the small lobe traverses through the membranes (Figure 5). In cases of absence 
of communicating blood vessels, it is called placenta spuria. The incidence of placenta 
succenturiata is about 3%. If the succenturiate lobe is retained, the following birth of the 
placenta may lead to:
a. Postpartum hemorrhage which may be primary or secondary
b. Subinvolution
c. Uterine sepsis
d. Polyp formation
Figure 4. Blood supply of placenta.
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Treatment: Whenever the diagnosis of missing lobe is made, exploration of the uterus and 
removal of the lobe under general anesthesia is to be done.
4.2. Velamentous placenta
Normally, the umbilical cord inserts into the middle of the placenta as it develops. In vela-
mentous cord insertion, the umbilical cord inserts into the fetal membranes (chorioamniotic 
membranes) and then travels within the membranes to the placenta (between the amnion 
and the chorion). The exposed vessels are not protected by Wharton's jelly and hence are 
vulnerable to rupture (Figure 5). Rupture is especially likely if the vessels are near the cervix, 
in which case they may rupture in early labor, likely resulting in a stillbirth. Once it is diag-
nosed, baby should be delivered by cesarean section.
4.3. Battledore placenta
Umbilical cord may be attached in the center, off center, on the edge, or in the membranes 
of the placenta. Battledore placenta is a placenta in which the umbilical cord is attached at 
the placental margin. The shortest distance between the cord insertion and the placental 
edge is within 2 cm. The incidence of the battledore placenta is 7–9% in singleton pregnan-
cies and 24–33% in twin pregnancies [4, 5]. Complications associated with the battledore 
placenta are:
a. fetal distress
b. intrauterine growth restriction
Figure 5. Placental abnormalities.
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c. preterm labor
d. decreased birth weight of baby and placenta
4.4. Placenta extrachorialis
It can be:
1. Circumvallate placenta: the fetal surface is divided into a central depressed zone sur-
rounded by a thickened white ring which is usually complete. The ring is situated at vary-
ing distances from the margin of the placenta and is composed of a double fold of amnion 
and chorion with degenerated decidua (vera) and fibrin in between. Vessels radiate from 
the cord insertion as far as the ring and then disappear from view.
2. Placenta marginata: a thin fibrous ring is present at the margin of the chorionic plate where 
the fetal vessels appear to terminate.
There is increased chance of:
a. Abortion
b. Hydrorrhea gravidarum
c. Antepartum hemorrhage
d. Growth retardation of the baby
e. Preterm delivery
f. Retained placenta or membranes
4.5. Morbidly adherent placenta
Morbidly adherent placenta, which includes placenta accreta, increta, and percreta, implies an 
abnormal implantation of the placenta into the uterine wall (Figure 6). The incidence of pla-
centa accreta has increased significantly over the past several decades, with the main risk fac-
tors including prior cesarean section and placental previa. Sonographic markers of placenta 
accreta can be present as early as the first trimester and include a low uterine implantation of 
a gestational sac, multiple vascular lacunae within the placenta, loss of the normal hypoechoic 
retroplacental zone, and abnormality of the uterine serosa-bladder interface, among others.
a. Placenta accreta is an extremely rare form in which the placenta is directly anchored to 
the myometrium partially or completely without any intervening decidua. The probable 
cause is due to the absence of decidua basalis and poor development of the fibrinoid layer.
b. Placenta increta: The placenta invades whole thickness of myometrium.
c. Placenta percreta: The placenta penetrates whole of the myometrium and may reach up to 
the peritoneum or bladder.
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4.6. Gestational trophoblastic disease/neoplasm
Gestational trophoblastic disease is divided into molar and nonmolar tumors. Nonmolar 
tumors are grouped as gestational trophoblastic neoplasia. It is classified as:
a. Hydatidiform mole
i. Complete
ii. Partial
b. Gestational trophoblastic neoplasia
c. Invasive mole
d. Choriocarcinoma
e. Placental site trophoblastic tumor
f. Epithelioid trophoblastic tumor
4.7. Chorioangioma of placenta
Placental chorioangioma is the commonest benign tumor of the placenta. Its incidence 
is around 1% when examined microscopically and is seen more frequently in multiple 
Figure 6. Morbidly adherent placenta (A: Accrete, B:  Increta, C: Percreta).
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pregnancies and in female babies [6]. Chorioangiomas that are clinically evident are less com-
mon with an incidence between 1:3500 and 1:9000 births [6]. It is believed to arise by 16th day 
of fertilization, although there is no documentation of the tumor in the first trimester [7]. In the 
majority of cases, it is small or microscopic and of no clinical significance. If it increases in size 
>5 cm, then it may be associated with serious maternal and fetal complications (Figure 7) [6].
The pathogenesis of these neoplasms is controversial; however, they can originate from any 
part of the placenta excluding the trophoblastic tissues [8]. Three histological patterns of cho-
rioangiomas have been described: angiomatous, cellular, and degenerate [9];
• The angiomatous is the most common, with numerous small areas of endothelial tissue, 
capillaries, and blood vessels surrounded by placental stroma.
• The cellular pattern has abundant endothelial cells within a loose stroma.
• The degenerate pattern has calcification, necrosis, or hyalinization.
These lesions are sometimes classified as placental hamartomas rather than true neoplasia [10]. 
There is no malignant potential.
Large tumors probably act as arteriovenous shunts and cause complications. Maternal compli-
cations are preeclampsia, preterm labor, placental abruption, polyhydramnios, and postpar-
tum hemorrhage [11]. The correlation of chorioangioma with hydramnios and preterm delivery 
is found to be significant among the various reported clinical complications. Fetal congestive 
heart failure may develop because of the increased blood flow through the low resistance vas-
cular channels in the chorioangioma acting as an arteriovenous shunt. Other associated fetal 
complications are nonimmune hydrops, fetal demise, hemolytic anemia, congenital anomalies, 
fetal thrombocytopenia, cardiomegaly, intrauterine growth restriction, and neonatal death [12].
Figure 7. Chorioangioma of placenta.
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Antenatal ultrasound examination has made diagnosis and follow up possible before delivery. 
In the present case, the placental tumor was not diagnosed in the ultrasound documentation 
rather polyhydramnios was reported. Doppler ultrasound examination is the gold standard in 
primary diagnosis of hemangioma. But unfortunately, we could not conduct Doppler USG in 
the present case as delivery was imminent. Magnetic resonance imaging (MRI) is used only 
in suspicious cases, while the computed tomography (CT) technique has a limited role in the 
diagnosis of the placental angioma, mainly because of the high radiation risk and poor tissue 
differentiation.
Chorioangioma with complications before fetal viability requires interventions. Alcohol 
injection, laser coagulation of feeding vessels, and microcoil embolization of the feeding 
vessels are described for women with fetal complications like hydrops [13, 14]. Large cho-
rioangioma associated with polyhydramnios leads to high perinatal morbidity and mortal-
ity. Polyhydramnios is treated with therapeutic amniocentesis and maternal indomethacin 
therapy [12]. Steroid administration for acceleration of fetal lung maturity before 34 weeks is 
indicated. If complications appear late in pregnancy, delivery is the choice. A recent literature 
review concluded that further studies are needed to refine the appropriate selection criteria 
that will justify the risk of invasive in utero therapy for chorioangiomas [15].
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